Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Don't Be Fooled By Celsion's Latest Rally
Seeking Alpha
Saturday, July 20, 2013 - 11:02am
tags:
Celsion
Hisun Pharmaceutical Doubles Down On Celsion
Seeking Alpha
Saturday, July 20, 2013 - 11:01am
tags:
Hisun, Celsion
DEALTALK-Biotech takeover interest more fad than fashion
Reuters
Saturday, July 20, 2013 - 10:54am
tags:
M&A
Iroko Pharmaceuticals Unveils Estimated Terms of IPO
Wall Street Journal
Saturday, July 20, 2013 - 10:50am
tags:
Iroko Pharmaceuticals
Actelion Beats on Earnings and Revs
Yahoo/Zacks
Friday, July 19, 2013 - 12:12pm
tags:
earnings, Actelion
DNA Giant Illumina's Newest Partnership
Seeking Alpha
Friday, July 19, 2013 - 12:09pm
tags:
Illumina, DNA, OPKO Health, Prolor Biotech, TrovaGene
Intuitive Surgical Declines on Warning Letter From FDA
Bloomberg
Friday, July 19, 2013 - 12:07pm
tags:
devices, warnings, FDA, Intuitive Surgical, robotic surgery
Medical Pot: A Drugmaker Bets on Marijuana to Treat Diabetes, Epilepsy, and More
Bloomberg/Businessweek
Friday, July 19, 2013 - 12:05pm
tags:
marijuana, GW Pharma, diabetes, epilepsy, Sativex, multiple sclerosis
Arena Stock Reacts To Sales Pace
Seeking Alpha
Friday, July 19, 2013 - 11:48am
tags:
Vivus, Arena Pharmaceuticals, Eisai, Belviq, Qsymia
The Deal: OncoMed IPO Goes Metastatic
TheStreet.com
Friday, July 19, 2013 - 11:45am
tags:
IPOs, OncoMed, stem cells
Has Pfizer Decided Not to Bother with Pricey Onyx?
Wall St. Cheat Sheet
Friday, July 19, 2013 - 11:43am
tags:
Pfizer, ONYX Pharmaceuticals
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Friday, July 19, 2013 - 11:38am
tags:
hepatitis C, AbbVie, Bristol-Myers Squibb, Gilead, Idenix, sofosbuvir, ledipasvir, daclatasvir, asunaprevir, BMS-791325, IDX20963
Earnings Miss at Cubist Pharma
Yahoo/Zacks
Friday, July 19, 2013 - 11:28am
tags:
Cubist Pharmaceuticals, earnings
Obesity drugmaker Vivus agrees to settlement with First Manhattan; Zook expected to become CEO
Yahoo/AP
Friday, July 19, 2013 - 10:33am
tags:
Vivus, obesity, Anthony Zook
The U.S. Antidepressant Market: Old Fashioned Branding Might Save the Day
Motley Fool
Friday, July 19, 2013 - 10:31am
tags:
antidepressants, AstraZeneca, Eli Lilly, Forest Labs, GSK, Pfizer, Targacept, Cymbalta, Lexapro, Effexor, Pristiq, TC-5214
Merck Pays $23 Million to End Vioxx Drug-Purchase Suits
Bloomberg
Friday, July 19, 2013 - 10:28am
tags:
Merck, Vioxx, settlements
UCB Visited by Chinese Authorities Amid Glaxo Probe
Bloomberg
Friday, July 19, 2013 - 10:19am
tags:
UCB Pharmaceuticals, GSK, China
The Future of Sanofi's Insulin Empire
Motley Fool
Friday, July 19, 2013 - 10:17am
tags:
Sanofi, insulin, Eli Lilly, Novo Nordisk, diabetes, U300, Lantus, LixiLan
FDA Fees to Review Drugs Would Be Unfrozen in House Bill
Bloomberg
Friday, July 19, 2013 - 10:15am
tags:
FDA, drug approvals
Glaxo Executive Unable to Leave China Amid Probe
Bloomberg
Thursday, July 18, 2013 - 11:40am
tags:
GSK, China

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.